XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities    
Net income (loss) $ 327,347 $ (194,106)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 197,816 174,063
Provision for severance benefits 117,243 124,056
Equity-based compensation 240,098 191,584
Non-cash operating lease expense 247,938 231,333
Other 99,594 56,536
Change in operating assets and liabilities:    
Accounts receivable, net (114,032) (39,325)
Inventories (86,692) (288,761)
Other assets (65,268) (273,554)
Accounts payable 1,235,365 163,508
Accrued expenses 15,400 (6,359)
Other liabilities (172,116) (154,012)
Net cash provided by (used in) operating activities 2,042,693 (15,037)
Investing activities    
Purchases of property and equipment (662,273) (703,074)
Proceeds from sale of property and equipment 12,461 10,600
Other investing activities (13,898) (25,979)
Net cash used in investing activities (663,710) (718,453)
Financing activities    
Proceeds from issuance of common stock, equity-based compensation plan 7,826 14,998
Proceeds from short-term borrowings and long-term debt 416,508 543,185
Repayment of short-term borrowings and long-term debt (63,654) (337,071)
Net short-term borrowings and other financing activities 1,222 5,377
Net cash provided by financing activities 361,902 226,489
Effect of exchange rate changes on cash and cash equivalents, and restricted cash (167,549) (243,132)
Net increase (decrease) in cash and cash equivalents, and restricted cash 1,573,336 (750,133)
Cash and cash equivalents, and restricted cash, as of beginning of period 3,687,274 3,810,347
Cash and cash equivalents, and restricted cash, as of end of period $ 5,260,610 $ 3,060,214